(Q46447210)

English

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

0 references

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

C Berne

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

Orlistat Swedish Type 2 diabetes Study Group

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

22

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

612-618

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Obesity prevention: the case for action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

The prevention and treatment of obesity. Application to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Long-term effects of modest weight loss in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01474.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2004.01474.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15842517

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46447210&oldid=2112009984"